Company Profiles

driven by the PitchBook Platform

Cylene Pharmaceuticals

Description

Developer of small molecule drugs that target nucleolus and kill cancer cells. The company offers nucleolus targeting agents, which are small-molecule targeted cancer therapeutic agents for carcinoid/neuroendocrine tumors and pediatric brain tumors and serine/threonine protein kinase inhibitors. It also provides pre-clinical stage oral drug candidates.

1997

Founded

PRIVATE

Status

1-10

Employees

Conv. Debt

Latest Deal Type

$867k

Latest Deal Amount

$106M

Total Amount Raised

Description

Developer of small molecule drugs that target nucleolus and kill cancer cells. The company offers nucleolus targeting agents, which are small-molecule targeted cancer therapeutic agents for carcinoid/neuroendocrine tumors and pediatric brain tumors and serine/threonine protein kinase inhibitors. It also provides pre-clinical stage oral drug candidates.

Website:

www.cylenepharma.com

Formerly Known As

Cyternex

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Primary Office

5820 Nancy Ridge Drive Suite 200 San Diego, CA 92121United States +1 (858) 875-5100
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Cylene Pharmaceuticals's full profile, request a free trial.

Cylene Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Cylene Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Cylene Pharmaceuticals Investors (16)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
BioVentures InvestorsVenture CapitalMinority000 0000000 0000
CelgeneCorporationMinority000 0000000 0000
Coastview CapitalVenture CapitalMinority000 0000000 0000
HBM Healthcare InvestmentsVenture CapitalMinority000 0000000 0000
IngleWood VenturesVenture CapitalMinority000 0000000 0000
BioVentures Investors Venture Capital
Celgene Corporation
Coastview Capital Venture Capital
HBM Healthcare Investments Venture Capital
IngleWood Ventures Venture Capital

Cylene Pharmaceuticals Executive Team (1)

NameTitleBoard
Seat
Contact
Info
Daniel Von Hoff MDCo-Founder & Senior Vice President, Medical Affairs
Daniel Von Hoff MD Co-Founder & Senior Vice President, Medical Affairs

Cylene Pharmaceuticals Board Members (5)

NameRepresentingRoleSinceContact
Info
Fred MiddletonSanderling VenturesManaging Director000 0000
Peter FeinsteinBioVentures InvestorsCo-Founder, Managing Director & General Partner000 0000
Reinhard Ambros Ph.DNovartis Venture FundsPresident000 0000
S. Edward TorresLilly VenturesCo-Founder & Managing Director000 0000
William Rice Ph.DSelfChairman000 0000
Fred Middleton Managing Director Sanderling Ventures
Peter Feinstein Co-Founder, Managing Director & General Partner BioVentures Investors
Reinhard Ambros Ph.D President Novartis Venture Funds
S. Edward Torres Co-Founder & Managing Director Lilly Ventures
William Rice Ph.D Chairman Self
Request full access to PitchBook